The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses.
Ensign Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$78.91|
|52 Week High||US$53.46|
|52 Week Low||US$98.66|
|1 Month Change||-3.57%|
|3 Month Change||-5.36%|
|1 Year Change||43.97%|
|3 Year Change||117.80%|
|5 Year Change||268.22%|
|Change since IPO||877.82%|
Recent News & Updates
What Does The Ensign Group, Inc.'s (NASDAQ:ENSG) Share Price Indicate?
While The Ensign Group, Inc. ( NASDAQ:ENSG ) might not be the most widely known stock at the moment, it received a lot...
Are Investors Undervaluing The Ensign Group, Inc. (NASDAQ:ENSG) By 29%?
Does the August share price for The Ensign Group, Inc. ( NASDAQ:ENSG ) reflect what it's really worth? Today, we will...
If You Like EPS Growth Then Check Out Ensign Group (NASDAQ:ENSG) Before It's Too Late
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
We Think Ensign Group (NASDAQ:ENSG) Can Manage Its Debt With Ease
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
|ENSG||US Healthcare||US Market|
Return vs Industry: ENSG exceeded the US Healthcare industry which returned 33% over the past year.
Return vs Market: ENSG exceeded the US Market which returned 33.7% over the past year.
Stable Share Price: ENSG is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: ENSG's weekly volatility (3%) has been stable over the past year.
About the Company
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. It operates in two segments, Transitional and Skilled Services and Real Estate. The company offers transitional and skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services.
Ensign Group Fundamentals Summary
|ENSG fundamental statistics|
Is ENSG overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ENSG income statement (TTM)|
|Cost of Revenue||US$2.05b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||3.48|
|Net Profit Margin||7.54%|
How did ENSG perform over the long term?See historical performance and comparison
0.3%Current Dividend Yield
Is Ensign Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ENSG ($78.91) is trading below our estimate of fair value ($116.88)
Significantly Below Fair Value: ENSG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ENSG is poor value based on its PE Ratio (22.9x) compared to the US Healthcare industry average (22.5x).
PE vs Market: ENSG is poor value based on its PE Ratio (22.9x) compared to the US market (17.8x).
Price to Earnings Growth Ratio
PEG Ratio: ENSG is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: ENSG is overvalued based on its PB Ratio (4.6x) compared to the US Healthcare industry average (3.3x).
How is Ensign Group forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ENSG's forecast earnings growth (10.5% per year) is above the savings rate (2%).
Earnings vs Market: ENSG's earnings (10.5% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: ENSG's earnings are forecast to grow, but not significantly.
Revenue vs Market: ENSG's revenue (9% per year) is forecast to grow slower than the US market (9.7% per year).
High Growth Revenue: ENSG's revenue (9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ENSG's Return on Equity is forecast to be high in 3 years time
How has Ensign Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ENSG has high quality earnings.
Growing Profit Margin: ENSG's current net profit margins (7.5%) are higher than last year (5.8%).
Past Earnings Growth Analysis
Earnings Trend: ENSG's earnings have grown significantly by 33.5% per year over the past 5 years.
Accelerating Growth: ENSG's earnings growth over the past year (43.9%) exceeds its 5-year average (33.5% per year).
Earnings vs Industry: ENSG earnings growth over the past year (43.9%) exceeded the Healthcare industry 32.2%.
Return on Equity
High ROE: ENSG's Return on Equity (20.4%) is considered high.
How is Ensign Group's financial position?
Financial Position Analysis
Short Term Liabilities: ENSG's short term assets ($567.1M) exceed its short term liabilities ($461.0M).
Long Term Liabilities: ENSG's short term assets ($567.1M) do not cover its long term liabilities ($1.3B).
Debt to Equity History and Analysis
Debt Level: ENSG's debt to equity ratio (12.3%) is considered satisfactory.
Reducing Debt: ENSG's debt to equity ratio has reduced from 43.4% to 12.3% over the past 5 years.
Debt Coverage: ENSG's debt is well covered by operating cash flow (269.1%).
Interest Coverage: ENSG's interest payments on its debt are well covered by EBIT (57.4x coverage).
What is Ensign Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ENSG's dividend (0.27%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.34%).
High Dividend: ENSG's dividend (0.27%) is low compared to the top 25% of dividend payers in the US market (3.58%).
Stability and Growth of Payments
Stable Dividend: ENSG is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: ENSG is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: ENSG is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ENSG's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Barry Port (47 yo)
Mr. Barry R. Port serves as Chief Executive Officer and Director at The Ensign Group, Inc. since May 30, 2019 and has been its President. Mr. Port has been Chief Operating Officer of Ensign Services, Inc a...
CEO Compensation Analysis
Compensation vs Market: Barry's total compensation ($USD6.52M) is about average for companies of similar size in the US market ($USD5.25M).
Compensation vs Earnings: Barry's compensation has been consistent with company performance over the past year.
Experienced Management: ENSG's management team is seasoned and experienced (7.6 years average tenure).
Experienced Board: ENSG's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.7%.
The Ensign Group, Inc.'s employee growth, exchange listings and data sources
- Name: The Ensign Group, Inc.
- Ticker: ENSG
- Exchange: NasdaqGS
- Founded: 1999
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$4.308b
- Shares outstanding: 54.59m
- Website: https://www.ensigngroup.net
Number of Employees
- The Ensign Group, Inc.
- 29222 Rancho Viejo Road
- Suite 127
- San Juan Capistrano
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/16 22:52|
|End of Day Share Price||2021/09/16 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.